CARL
Carlsmed, Inc.
$11.42
-3.30%
2026-05-29
About Carlsmed, Inc.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Key Fundamentals
Forward P/E
-6.96
EPS (TTM)
$-0.98
ROE
-52.4%
Revenue Growth (YoY)
58.2%
Profit Margin
-57.8%
Debt/Equity
18.70
Price/Book
2.69
Market Cap
$271.6M
Avg Volume (10D)
119K
Recent Breakout Signals
No recent breakout signals detected for CARL.
Recent Price Range (60 Days)
60D High
$13.08
60D Low
$8.50
Avg Volume
155K
Latest Close
$11.42
Get breakout alerts for CARL
Sign up for Breakout Scanner to receive daily notifications when CARL triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
Carlsmed, Inc. (CARL) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors CARL daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. CARL operates in the Healthcare sector within the Health Information Services industry. Data is provided for informational purposes only and does not constitute financial advice.